Santen Pharmaceutical Asia

Santen is a specialized pharmaceutical company dedicated to ophthalmology, holding a leading market share in the ophthalmic treatment area in Japan and a significant presence globally. The company focuses on the research, development, and commercialization of innovative treatments for eye diseases such as glaucoma, dry eye, and retinal disorders. Santen's portfolio includes a wide range of prescription pharmaceuticals, over-the-counter eye drops, and medical devices. With a strong focus on the Asian market, the company operates through various subsidiaries, including Santen Pharmaceutical Asia, to address the growing demand for eye care in the region. Santen is committed to its World Vision 2030 goal of becoming a Social Innovator in the eye health field.